Koers International Stem Cell Corp OTC Bulletin Board
Aandelen
ISCO
US4603781026
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | 8,18 mln. 7,6 mln. | Omzet 2023 | 7,79 mln. 7,24 mln. | Marktkapitalisatie | 496K 461K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 0,61 x |
Nettoschuld 2022 | 3,53 mln. 3,28 mln. | Nettoschuld 2023 | 2,59 mln. 2,41 mln. | EV/omzet 2023 | 0,4 x |
K/w-verhouding 2022 |
-4,35
x | K/w-verhouding 2023 |
-3,79
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 27,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 01-12-08 |
Russell Kern
DFI | Director of Finance/CFO | 38 | 01-10-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Russell Kern
DFI | Director of Finance/CFO | 38 | 01-10-08 |
Paul Maier
BRD | Director/Board Member | 76 | 01-07-07 |
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 01-12-08 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,86 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,66 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+28,07% | 12,14 mld. | |
+0,17% | 12,15 mld. | |
-1,24% | 11,99 mld. |
- Beurs
- Aandelen
- Koers ISCO
- Koers ISCO